CJC-1295 with DAC
CJC-1295 with DAC is an analog of the endogenous peptide growth hormone-releasing hormone, or GHRH. GHRH binds to a specific receptor called growth hormone-releasing hormone receptor, or GHRHR, and proceeds to block growth hormone production.Regular functioning of GHRH restricts the amount of growth hormone released into the body.
This is due to GHRH’s short half-life. Within the same systems, CJC-1295 with DAC intercepts and binds itself to GHRHR. Having a much longer half-life, CJC-1295 with DAC potentially results in longer secretion of growth hormones.
There are several studies relating to CJC-1295 with DAC and its effects. A study on healthy adults pointed towards increased growth hormone levels. Adults widely varying in age were injected with CJC-1295 with DAC. Subjects were observed to have greater amounts of growth hormones within their blood.
A study on rats demonstrated the longer half-life of the peptide, as subjects appeared to have higher levels of growth hormone than typical over several hours